Hiroshi Inaba Selected Research

Antigens

9/2023	Correction to "Antigen/Adjuvant-Displaying Enveloped Viral Replica as a Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidate".
1/2023	Antigen/Adjuvant-Displaying Enveloped Viral Replica as a Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidate.
1/2020	Immunological Evaluation of Co-Assembling a Lipidated Peptide Antigen and Lipophilic Adjuvants: Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidates.
12/2007	Molecular characterization of 3 factor V mutations, R2174L, V1813M, and a 5-bp deletion, that cause factor V deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Inaba Research Topics

Disease

6	Hemophilia A (Haemophilia) 11/2023 - 06/2013
6	Hemorrhage 01/2023 - 12/2007
3	Breast Neoplasms (Breast Cancer) 09/2023 - 01/2020
3	Neoplasms (Cancer) 01/2023 - 01/2022
2	Hemophilia B (Haemophilia B) 04/2023 - 05/2009
2	Infections 02/2022 - 04/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 04/2023
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Polymyositis 01/2013
1	Factor V Deficiency 12/2007
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2003

Drug/Important Bio-Agent (IBA)

4	AntigensIBA 09/2023 - 12/2007
4	Factor VIII (Coagulation Factor VIII)IBA 10/2022 - 01/2017
3	VaccinesIBA 09/2023 - 01/2020
3	Peptides (Polypeptides)IBA 01/2023 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 04/2018 - 12/2007
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 11/2023
1	Complementary DNA (cDNA)IBA 04/2023
1	SolutionsIBA 04/2023
1	A-Form DNA (A-DNA)IBA 01/2023
1	Nucleotide AptamersIBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Factor VIIIaIBA 01/2023
1	emicizumabIBA 01/2023
1	Thrombin FDA Link 10/2022
1	Culture MediaIBA 10/2022
1	Protein CIBA 10/2022
1	peptide AIBA 08/2022
1	Cell-Penetrating PeptidesIBA 08/2022
1	polyhistidineIBA 08/2022
1	GoldIBA 08/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2022
1	Lipid Bilayers (Lipid Bilayer)IBA 02/2022
1	Indicators and Reagents (Reagents)IBA 02/2022
1	EnzymesIBA 01/2022
1	ribonuclease SIBA 01/2022
1	Lipid AIBA 01/2020
1	Amino Acids FDA Link 06/2013
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2013
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 05/2009
1	Factor V (Coagulation Factor V)IBA 12/2007
1	AntithrombinsIBA 07/2003

Therapy/Procedure

1	Therapeutics 01/2023
1	Photothermal Therapy 08/2022